News Sep 29, 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
News Dec 04, 2023 Siegfried, a Swiss leader taking innovations to industrial scale for the pharmaceutical industry From a small operation in Aargau to a global CDMO powerhouse, Siegfried's journey reflects strategic growth, innovation, and a deep commitment to...
Actualités Jan 11, 2023 Le groupe Bachem décroche un contrat de fourniture de peptides de CHF 1 milliard Le récent contrat d’approvisionnement en peptides du groupe Bachem, d’un montant de CHF 1 milliard et d’une durée de cinq ans, permettra à l’entr...
News Oct 23, 2023 Valsynthèse, 40 years of innovation in the canton of Valais From dynamite to pharmaceuticals, Valsynthèse, the 'fine chemistry' business unit of the Société Suisse des Explosifs, celebrates four decades of...
News Oct 25, 2023 Mecaplast Swiss, 50 years of innovation in the canton of Fribourg With a rich history spanning five decades, Mecaplast Swiss has consistently proven itself as a leader in the plastic injection industry, particul...
News Oct 11, 2023 Lonza further extends its ADC manufacturing capabilities in Visp Lonza amplifies ADC production via a robust extension in bioconjugation capacity at its Ibex Dedicate Biopark in Visp, which set to generate 180 ...
News Oct 20, 2023 Lonza expands to manufacture Vaxcyte’s pneumococcal conjugate vaccine Lonza and US clinical-stage vaccine innovation company Vaxcyte have announced an expansion in their partnership to establish a global commercial ...
ニュース Mar 08, 2021 JOI Fes 2020→21に出展 スイスでオープンイノベーションを スイス・ビジネス・ハブ投資促進部は、スイス・イノベーションを代表し、2月26日にオンラインで開催された日本最大級オープンイノベーションカンファレンス「Japan Open Innovation Fes 2021」にブースを出展いたしました。 スイス・イノベーションは、スイス国内に5つのイ...
News Apr 06, 2017 Ricolab: Why an innovation laboratory can be worthwhile for SMEs Keeping pace with new technologies, consumer trends or the digital transformation represents a huge challenge for many SMEs
News Jun 02, 2023 Abiogen Pharma acquires majority stake in EffRx Abiogen, a pharmaceutical firm based in the Italian city of Pisa, has acquired a 97.09 percent stake in EffRx Pharmaceuticals. Since 2014, Abioge...
News Jan 11, 2023 Bachem Group secures CHF 1 billion peptide supply contract Bachem Group's recent CHF 1 billion peptide supply deal, spanning over five years will enable the company's plans to expand capacity across all i...
News May 26, 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
ニュース Jul 24, 2017 2017年上半期、日本企業によるM&Aが相次ぐ 2017年上半期は、日本企業によるスイス企業の買収が相次いで発表されました。企業価値の向上や既存事業の拡充など、世界規模で活動する日本企業の更なるグローバル展開の礎として、スイスの認知の高まりを見せています。